RGX-202
Oct 11, 2018
Orchard files for IPO; J&J puts money on RNA interference; Rgenix receives $40M; GSK gives a helping hand
Orchard files for USD173 Million IPO to run pivotal gene therapy trials Orchard Therapeutics, Transatlantic biotech, has filed to raise USD 173 million in an IPO. This will lead it to take three gene therapies through the clinic. Orchard recognised itself as one of the broadest clinical-phase gene therapy pipelines ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
